Study of the cytotoxic activity of di and triphenyltin(IV) carboxylate complexes

Journal of Inorganic Biochemistry

Volumn 102, Issue 12, 2008, Pages 2087-2096

  Gómez Ruiz, Santiago ^a,b   Kaluderović, Goran N ^c   Prashar, Sanjiv ^a   Hey Hawkins, Evamarie ^b   Erić, Aleksandra ^d   Žižak, Željko ^d   Juranić, Zorica D ^d  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Adenocarcinoma HeLa; Anticancer drugs; Human malignant melanoma Fem x; Human myelogenous leukemia K562; Tin

Indexed keywords

1,4 BENZODIOXANE 6 CARBOXYLIC ACID; 2,5 DIMETHYL 3 FUROIC ACID; 3 METHOXYPHENYLACETIC ACID; 4 METHOXYPHENYLACETIC ACID; CARBOXYLIC ACID DERIVATIVE; CISPLATIN; DIPHENYLTIN CHLORIDE; DIPHENYLTIN COMPLEX; TIN DERIVATIVE; TRIETHYLAMINE; TRIPHENYLTIN CHLORIDE; TRIPHENYLTIN COMPLEX; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN K 562; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; IC 50; IMMUNOCOMPETENT CELL; MELANOMA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; X RAY DIFFRACTION;

ANTINEOPLASTIC AGENTS; CARBOXYLIC ACIDS; CELL LINE, TUMOR; CYTOTOXINS; HELA CELLS; HUMANS; K562 CELLS; MOLECULAR STRUCTURE; NEOPLASMS; ORGANOTIN COMPOUNDS;

EID: 55549104361     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2008.07.009     Document Type: Article

References (41)

1. Medicinal Inorganic Chemistry, Special Thematic Issue, Chem. Rev., vol. 99, 1999.
2. In: Sessler J.L., Doctrow S.R., McMurry J., and Lippard S.J. (Eds). Medicinal Inorganic Chemistry. American Chemical Society Symposium Series 903 (2005), American Chemical Society, Washington, DC
3. Kalud{combining short stroke overlay}erović G.N., Miljković Dj., Momčilović M., D{combining short stroke overlay}inović V.M., Stojković M.M., Sabo T.J., and Trajković V. Int. J. Cancer 116 (2005) 479-486
4. Mijatović S., Maksimović-Ivanić D., Radović J., Miljković D., Kalud{combining short stroke overlay}erović G.N., Sabo T.J., and Trajković V. Cell. Mol. Life Sci. 62 (2005) 1275-1282
5. Kalud{combining short stroke overlay}erović G.N., D{combining short stroke overlay}inović V.M., Juranić Z.D., Stanojković T.P., and Sabo T.J. J. Inorg. Biochem. 99 (2005) 488-498
6. In: Nikolini M. (Ed). Platinum and Other Coordination Compounds in Cancer Chemotherapy (1998), Martinus-Nijhoff Publishing, Boston, MA
7. Ott I., and Gust R. Arch. Pharm. 340 (2007) 117-126
8. In: Gielen M. (Ed). Tin-Based Anti-Tumor Drugs (1990), Springer-Verlag, Berlin
9. Gielen M. Coord. Chem. Rev. 151 (1996) 41-51
10. Yang P., and Guo M. Coord. Chem. Rev. 185-186 (1999) 189-211
11. Gielen M., Biesemans M., De Vos D., and Willem R. J. Inorg. Biochem. 79 (2000) 139-145
12. Gielen M. Appl. Organomet. Chem. 16 (2002) 481-494
13. S.K. Hadjikakou, N. Hadjiliadis, Coord. Chem. Rev., in press. doi:10.1016/j.ccr.2007.12.026.
14. Nagy L., Szorcsik A., and Kovacs K. Pharm. Hungarica 70 (2000) 53-71
15. Nath M., Pokharia S., and Yadav R. Coord. Chem. Rev. 215 (2001) 99-149
16. M. Gielen, Tin-Based Antitumor Drugs, NATO ASI Series 2, vol. 26, 1997, pp. 445-455.
17. De Vos D., Willem R., Gielen M., Van Wingerden K.E., and Nooter K. Met.-Based Drugs 5 (1998) 179-188
18. Pettinari C. Main Group Met. Chem. 22 (1999) 661-692
19. In: Fricker S.P. (Ed). Metal Compounds in Cancer Therapy (1994), Chapman & Hall, London, UK 147-179
20. Atassi G. Rev. Silicon Germanium Tin Lead Compd. 8 (1985) 219-235
21. Gielen M. Main Group Met. Chem. 17 (1994) 1-8
22. Mirisola M.G., Pellerito A., Fiore T., Stocco G.C., Cestelli A., and Di Liegro I. Appl. Organomet. Chem. 11 (1997) 499-511
23. Kemmer M., Gielen M., Biesemans M., de Vos D., and Willem R. Met.-Based Drugs 5 (1998) 189-196
24. Saxena A.K., and Huber F. Coord. Chem. Rev. 95 (1989) 109-123
25. Susperregui J., Bayle M., Lain G., Giroud C., Baltz T., and Deleris G. Eur. J. Med. Chem. 34 (1999) 617-623
26. Pellerito L., and Nagy L. Coord. Chem. Rev. 224 (2002) 111-150
27. In: Gielen M., and Tiekink E.R.T. (Eds). Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine (2005), John Wiley & Sons, Ltd. 421
28. Basu Baul T.S., Rynjah W., Rivarola E., Lycka A., Holcapek M., Jirasko R., de Vos D., Butcher R.J., and Linden A. J. Organomet. Chem. 691 (2006) 4850-4862
29. Tian L., Sun Y., Li H., Zheng X., Cheng Y., Liu X., and Qian B. J. Inorg. Biochem. 99 (2005) 1646-1652
30. Han G., and Yang P. J. Inorg. Biochem. 91 (2002) 230-236
31. Gómez-Ruiz S., Kalud{combining short stroke overlay}erović G.N., Polo-Cerón D., Prashar S., Fajardo M., Žižak Z., Juranić Z.D., and Sabo T.J. Inorg. Chem. Commun. 10 (2007) 748-752
32. Gómez-Ruiz S., Kalud{combining short stroke overlay}erović G.N., Prashar S., Polo-Cerón D., Fajardo M., Žižak Z., Sabo T.J., and Juranić Z.D. J. Inorg. Biochem. 102 (2008) 1558-1570
33. SCALE3 ABSPACK: Empirical absorption correction, CrysAlis - Software Package, Oxford Diffraction Ltd., 2006.
34. G.M. Sheldrick, SHELXS-97, Program for Crystal Structure Solution, Göttingen, 1997.
35. G.M. Sheldrick, SHELXL-97, Program for the Refinement of Crystal Structures, Göttingen, 1997.
36. Mosmann T. J. Immunol. Methods 65 (1983) 55-63
37. Ohno M., and Abe T. J. Immunol. Methods 145 (1991) 199-203
38. Bellamy L.J. The Infra-red Spectra of Complex Molecules. third ed. (1975), Wiley, New York
39. Deacon G.B., and Philips R.J. Coord. Chem. Rev. 33 (1980) 227-250
40. Forrester A.R., Garden S.J., Howie R.A., and Wardell J.L. J. Chem. Soc., Dalton Trans. (1992) 2615-2621
41. Yin H.D., Wang Q.B., and Xue S.C. J. Organomet. Chem. 690 (2005) 435-440